Improving patient-important outcomes in haemodialysis through validation and implementation in registries and pragmatic clinical trials

血液透析是肾衰竭最常见的治疗方法，但与生存率低、症状负担高和生活质量急剧下降有关。研究通常不涉及这些对患者重要的结果，从而限制了我们发现有效干预措施的能力。该项目旨在通过临床实践、注册和临床试验的验证和实施，改善对患者和临床医生至关重要的血液透析结果。

Haemodialysis is the most common treatment for kidney failure but is associated with poor survival, high symptom burden and drastically reduced quality of life. Research often does not address these patient-important outcomes, thereby limiting our ability to discover effective interventions. This program aims to improve haemodialysis outcomes that are critically important to patients and clinicians through validation and implementation in clinical practice, registries and clinical trial.